Mesoblast Ltd - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Mesoblast Ltd. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Mesoblast Ltd. The Group's principal activity is developing biological products in the field of regenerative medicine. It is developing an adult stem cell platform for use in the global orthopedic industry, targeting a range of bone, cartilage and musculoskeletal conditions. The Group has the worldwide exclusive rights for orthopedic indications relating to a series of patents and technologies that have been developed over more than 10 years and which relate to the identification, extraction, and culture of adult Mesenchymal Precursor Cells (MPCs). The Group holds a substantial interest in Angioblast Systems Inc., an American company developing the same platform technology for the treatment of cardiovascular diseases, including repair and regeneration of blood vessels and heart muscle.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report